Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
MDXX-class molecules producer PharmAla Biotech Holdings Inc.
This Specialized MDMA Producer Will Provide Psychedelics Exclusively For Canadian Massive Research Organization
A new deal has been signed between PharmAla Biotech Holdings Inc. (CSE: MDMA) and InterVivo Solutions for GMP MDMA and engineering MDMA supply towards research on its impact on neuropsychiatric and neurological diseases.